Investors are closely examining the performance of two notable medical companies: Agilon Health (NYSE: AGL) and Amplifon (OTCMKTS: AMFPF). This analysis evaluates their valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations, and risk factors, aiming to determine which company stands out in the competitive healthcare market.
Profitability and Earnings Comparison
A detailed assessment reveals key differences in profitability between the two companies. Agilon Health and Amplifon exhibit varying net margins, return on equity, and return on assets. While Amplifon showcases stronger earnings performance, it is important to note that its gross revenue is lower than that of Agilon Health. Currently, Agilon Health is trading at a price-to-earnings ratio that suggests it is more affordable compared to Amplifon, indicating a potential investment opportunity for those seeking value.
Analyst recommendations also provide insight into the perceived future performance of these companies. According to MarketBeat, Agilon Health has a consensus price target of $2.71, which translates to a potential upside of 277.73%. This substantial upside has led analysts to favor Agilon Health over Amplifon, suggesting a more optimistic outlook for investors.
Risk and Volatility Assessment
When evaluating risk, Agilon Health demonstrates a beta of 0.06, indicating its share price is significantly less volatile—by 94%—compared to the S&P 500. In contrast, Amplifon has a beta of 0.45, meaning it is 55% less volatile than the same index. This distinction highlights Agilon Health’s stability as a potentially safer investment.
Despite Agilon Health’s favorable risk profile, Amplifon excels in nine out of twelve categories in this comparative analysis. This suggests that while Agilon Health may hold certain advantages in valuation and future potential, Amplifon has a more established track record across a broader range of factors.
Agilon Health, based in Austin, Texas, was founded in 2016 and operates to provide healthcare services for seniors. The company offers a subscription-like platform that manages the comprehensive healthcare needs of its patients. Initially named Agilon Health Topco, Inc., it rebranded in March 2021.
Conversely, Amplifon, founded in 1950 and headquartered in Milan, Italy, specializes in the distribution of hearing solutions. Its product offerings include a range of customized devices designed to enhance the auditory experience for users. Amplifon also operates the Ampli-care platform, which facilitates audiological care, along with the Amplifon App that allows users to manage device functions directly from their smartphones.
Overall, while both Agilon Health and Amplifon have distinct strengths and weaknesses, the decision on which company represents the superior investment opportunity ultimately depends on individual investor priorities. Whether valuing potential growth or established performance, careful consideration will be necessary as the healthcare sector continues to evolve.
